25 XP   0   0   10

Tibet Weixinkang Medicine Co Ltd
Buy, Hold or Sell?

Let's analyse Tibet Weixinkang Medicine Co Ltd together

PenkeI guess you are interested in Tibet Weixinkang Medicine Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tibet Weixinkang Medicine Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tibet Weixinkang Medicine Co Ltd

I send you an email if I find something interesting about Tibet Weixinkang Medicine Co Ltd.

Quick analysis of Tibet Weixinkang Medicine Co Ltd (30 sec.)










What can you expect buying and holding a share of Tibet Weixinkang Medicine Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.09
When do you have the money?
1 year
How often do you get paid?
88.9%

What is your share worth?

Current worth
¥2.80
Expected worth in 1 year
¥4.23
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥2.06
Return On Investment
24.3%

For what price can you sell your share?

Current Price per Share
¥8.48
Expected price per share
¥6.3 - ¥9.07
How sure are you?
50%

1. Valuation of Tibet Weixinkang Medicine Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥8.48

Intrinsic Value Per Share

¥4.40 - ¥6.14

Total Value Per Share

¥7.20 - ¥8.94

2. Growth of Tibet Weixinkang Medicine Co Ltd (5 min.)




Is Tibet Weixinkang Medicine Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$168.4m$147.2m$21.1m12.6%

How much money is Tibet Weixinkang Medicine Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$24.4m$13.2m$11.1m45.8%
Net Profit Margin12.7%9.3%--

How much money comes from the company's main activities?

3. Financial Health of Tibet Weixinkang Medicine Co Ltd (5 min.)




What can you expect buying and holding a share of Tibet Weixinkang Medicine Co Ltd? (5 min.)

Welcome investor! Tibet Weixinkang Medicine Co Ltd's management wants to use your money to grow the business. In return you get a share of Tibet Weixinkang Medicine Co Ltd.

What can you expect buying and holding a share of Tibet Weixinkang Medicine Co Ltd?

First you should know what it really means to hold a share of Tibet Weixinkang Medicine Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Tibet Weixinkang Medicine Co Ltd is ¥8.48. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tibet Weixinkang Medicine Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tibet Weixinkang Medicine Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.80. Based on the TTM, the Book Value Change Per Share is ¥0.36 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.19 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.16 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tibet Weixinkang Medicine Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.060.7%0.060.7%0.030.4%0.030.3%0.030.3%
Usd Book Value Change Per Share0.050.6%0.050.6%0.030.3%0.020.3%0.040.5%
Usd Dividend Per Share0.020.3%0.020.3%0.010.1%0.010.1%0.010.1%
Usd Total Gains Per Share0.070.8%0.070.8%0.040.5%0.030.4%0.050.6%
Usd Price Per Share2.20-2.20-1.28-1.55-1.11-
Price to Earnings Ratio39.15-39.15-42.23-59.61-40.75-
Price-to-Total Gains Ratio30.91-30.91-33.13-53.59-47.55-
Price to Book Ratio5.68-5.68-3.80-4.78-3.56-
Price-to-Total Gains Ratio30.91-30.91-33.13-53.59-47.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.17024
Number of shares854
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.01
Usd Book Value Change Per Share0.050.02
Usd Total Gains Per Share0.070.03
Gains per Quarter (854 shares)60.6929.65
Gains per Year (854 shares)242.77118.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1741682334079109
214933747680157228
3223505719120236347
4297674962160314466
53728421205200393585
644610101448240471704
752111791691280550823
859513471934320628942
9669151621773617071061
10744168424204017851180

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.01.088.9%8.00.01.088.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.01.088.9%8.00.01.088.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.00.00.0100.0%9.00.00.0100.0%

Fundamentals of Tibet Weixinkang Medicine Co Ltd

About Tibet Weixinkang Medicine Co Ltd

Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of chemical drugs and their bulk drugs in China. The company offers parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases, and other special fields. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.

Fundamental data was last updated by Penke on 2024-04-18 13:33:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Tibet Weixinkang Medicine Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tibet Weixinkang Medicine Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 12.7% means that ¥0.13 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 12.7%. The company is making a huge profit. +2
  • The TTM is 12.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ12.7%TTM12.7%0.0%
TTM12.7%YOY9.3%+3.4%
TTM12.7%5Y9.5%+3.2%
5Y9.5%10Y11.0%-1.5%
1.1.2. Return on Assets

Shows how efficient Tibet Weixinkang Medicine Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 10.6% Return on Assets means that Tibet Weixinkang Medicine Co Ltd generated ¥0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 10.6%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 10.6%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ10.6%TTM10.6%0.0%
TTM10.6%YOY6.4%+4.2%
TTM10.6%5Y6.3%+4.3%
5Y6.3%10Y6.9%-0.6%
1.1.3. Return on Equity

Shows how efficient Tibet Weixinkang Medicine Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 14.5% Return on Equity means Tibet Weixinkang Medicine Co Ltd generated ¥0.14 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 14.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.5%TTM14.5%0.0%
TTM14.5%YOY9.0%+5.5%
TTM14.5%5Y8.7%+5.8%
5Y8.7%10Y8.9%-0.2%

1.2. Operating Efficiency of Tibet Weixinkang Medicine Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tibet Weixinkang Medicine Co Ltd is operating .

  • Measures how much profit Tibet Weixinkang Medicine Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.4%-9.4%
TTM-5Y5.1%-5.1%
5Y5.1%10Y8.3%-3.2%
1.2.2. Operating Ratio

Measures how efficient Tibet Weixinkang Medicine Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.35 means that the operating costs are ¥1.35 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 1.354. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.354. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.354TTM1.3540.000
TTM1.354YOY1.390-0.035
TTM1.3545Y1.430-0.076
5Y1.43010Y1.125+0.305

1.3. Liquidity of Tibet Weixinkang Medicine Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tibet Weixinkang Medicine Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.77 means the company has ¥2.77 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 2.766. The company is able to pay all its short-term debts. +1
  • The TTM is 2.766. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.766TTM2.7660.000
TTM2.766YOY2.407+0.359
TTM2.7665Y2.518+0.248
5Y2.51810Y2.233+0.284
1.3.2. Quick Ratio

Measures if Tibet Weixinkang Medicine Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.23 means the company can pay off ¥1.23 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 1.229. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.229. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.229TTM1.2290.000
TTM1.229YOY1.574-0.345
TTM1.2295Y1.385-0.155
5Y1.38510Y1.345+0.040

1.4. Solvency of Tibet Weixinkang Medicine Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tibet Weixinkang Medicine Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Tibet Weixinkang Medicine Co Ltd assets are financed with 26.7% credit (debt) and the remaining percentage (100% - 26.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 0.267. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.267. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.267TTM0.2670.000
TTM0.267YOY0.286-0.020
TTM0.2675Y0.278-0.011
5Y0.27810Y0.237+0.041
1.4.2. Debt to Equity Ratio

Measures if Tibet Weixinkang Medicine Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 36.4% means that company has ¥0.36 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The MRQ is 0.364. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.364. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.3640.000
TTM0.364YOY0.401-0.037
TTM0.3645Y0.385-0.022
5Y0.38510Y0.316+0.069

2. Market Valuation of Tibet Weixinkang Medicine Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Tibet Weixinkang Medicine Co Ltd generates.

  • Above 15 is considered overpriced but always compare Tibet Weixinkang Medicine Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 39.15 means the investor is paying ¥39.15 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The EOD is 20.853. Based on the earnings, the company is fair priced.
  • The MRQ is 39.149. Based on the earnings, the company is overpriced. -1
  • The TTM is 39.149. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD20.853MRQ39.149-18.296
MRQ39.149TTM39.1490.000
TTM39.149YOY42.234-3.085
TTM39.1495Y59.610-20.461
5Y59.61010Y40.751+18.859
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The EOD is 21.905. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 41.124. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 41.124. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD21.905MRQ41.124-19.219
MRQ41.124TTM41.1240.000
TTM41.124YOY35.196+5.928
TTM41.1245Y-46.728+87.853
5Y-46.72810Y-79.581+32.853
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tibet Weixinkang Medicine Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Tibet Weixinkang Medicine Co Ltd:

  • The EOD is 3.023. Based on the equity, the company is fair priced.
  • The MRQ is 5.676. Based on the equity, the company is overpriced. -1
  • The TTM is 5.676. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.023MRQ5.676-2.653
MRQ5.676TTM5.6760.000
TTM5.676YOY3.795+1.880
TTM5.6765Y4.776+0.900
5Y4.77610Y3.557+1.219
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Tibet Weixinkang Medicine Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3570.3570%0.188+90%0.167+114%0.312+15%
Book Value Per Share--2.8052.8050%2.448+15%2.342+20%1.814+55%
Current Ratio--2.7662.7660%2.407+15%2.518+10%2.233+24%
Debt To Asset Ratio--0.2670.2670%0.286-7%0.278-4%0.237+12%
Debt To Equity Ratio--0.3640.3640%0.401-9%0.385-6%0.316+15%
Dividend Per Share--0.1580.1580%0.092+71%0.085+86%0.079+101%
Eps--0.4070.4070%0.220+85%0.212+92%0.202+102%
Free Cash Flow Per Share--0.3870.3870%0.264+47%0.190+103%0.152+155%
Free Cash Flow To Equity Per Share--0.3870.3870%0.278+39%0.175+122%0.203+91%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.778+29%
Intrinsic Value_10Y_max--6.139--------
Intrinsic Value_10Y_min--4.395--------
Intrinsic Value_1Y_max--0.351--------
Intrinsic Value_1Y_min--0.256--------
Intrinsic Value_3Y_max--1.257--------
Intrinsic Value_3Y_min--0.933--------
Intrinsic Value_5Y_max--2.405--------
Intrinsic Value_5Y_min--1.786--------
Market Cap3690173624.320-88%6927778785.2806927778785.2800%4050709410.000+71%4882387728.272+42%3487992984.969+99%
Net Profit Margin--0.1270.1270%0.093+36%0.095+33%0.110+16%
Operating Margin----0%0.094-100%0.051-100%0.083-100%
Operating Ratio--1.3541.3540%1.390-3%1.430-5%1.125+20%
Pb Ratio3.023-88%5.6765.6760%3.795+50%4.776+19%3.557+60%
Pe Ratio20.853-88%39.14939.1490%42.234-7%59.610-34%40.751-4%
Price Per Share8.480-88%15.92015.9200%9.290+71%11.216+42%8.013+99%
Price To Free Cash Flow Ratio21.905-88%41.12441.1240%35.196+17%-46.728+214%-79.581+294%
Price To Total Gains Ratio16.467-88%30.91430.9140%33.126-7%53.588-42%47.550-35%
Quick Ratio--1.2291.2290%1.574-22%1.385-11%1.345-9%
Return On Assets--0.1060.1060%0.064+66%0.063+68%0.069+53%
Return On Equity--0.1450.1450%0.090+61%0.087+66%0.089+62%
Total Gains Per Share--0.5150.5150%0.280+84%0.252+105%0.390+32%
Usd Book Value--168440792.783168440792.7830%147282447.579+14%140725508.394+20%108949813.106+55%
Usd Book Value Change Per Share--0.0490.0490%0.026+90%0.023+114%0.043+15%
Usd Book Value Per Share--0.3870.3870%0.338+15%0.323+20%0.250+55%
Usd Dividend Per Share--0.0220.0220%0.013+71%0.012+86%0.011+101%
Usd Eps--0.0560.0560%0.030+85%0.029+92%0.028+102%
Usd Free Cash Flow--23247362.26923247362.2690%15882454.914+46%11433497.636+103%9136429.817+154%
Usd Free Cash Flow Per Share--0.0530.0530%0.036+47%0.026+103%0.021+155%
Usd Free Cash Flow To Equity Per Share--0.0530.0530%0.038+39%0.024+122%0.028+91%
Usd Market Cap509243960.156-88%956033472.369956033472.3690%558997898.580+71%673769506.502+42%481343031.926+99%
Usd Price Per Share1.170-88%2.1972.1970%1.282+71%1.548+42%1.106+99%
Usd Profit--24420297.71024420297.7100%13235731.560+85%12707269.331+92%10379308.643+135%
Usd Revenue--192998937.825192998937.8250%142639908.418+35%127929321.107+51%96797289.881+99%
Usd Total Gains Per Share--0.0710.0710%0.039+84%0.035+105%0.054+32%
 EOD+4 -4MRQTTM+0 -0YOY+29 -65Y+29 -610Y+27 -9

3.2. Fundamental Score

Let's check the fundamental score of Tibet Weixinkang Medicine Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.853
Price to Book Ratio (EOD)Between0-13.023
Net Profit Margin (MRQ)Greater than00.127
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.229
Current Ratio (MRQ)Greater than12.766
Debt to Asset Ratio (MRQ)Less than10.267
Debt to Equity Ratio (MRQ)Less than10.364
Return on Equity (MRQ)Greater than0.150.145
Return on Assets (MRQ)Greater than0.050.106
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Tibet Weixinkang Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.696
Ma 20Greater thanMa 508.208
Ma 50Greater thanMa 1008.182
Ma 100Greater thanMa 2009.106
OpenGreater thanClose8.200
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Interest Income  -258-374-632441-191103-893,1343,045



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,664,718
Total Liabilities444,133
Total Stockholder Equity1,220,585
 As reported
Total Liabilities 444,133
Total Stockholder Equity+ 1,220,585
Total Assets = 1,664,718

Assets

Total Assets1,664,718
Total Current Assets1,138,972
Long-term Assets525,746
Total Current Assets
Cash And Cash Equivalents 519,322
Short-term Investments 287,000
Net Receivables 219,228
Inventory 32,541
Other Current Assets 3,422
Total Current Assets  (as reported)1,138,972
Total Current Assets  (calculated)1,061,514
+/- 77,458
Long-term Assets
Property Plant Equipment 333,734
Intangible Assets 62,454
Long-term Assets Other 25,286
Long-term Assets  (as reported)525,746
Long-term Assets  (calculated)421,474
+/- 104,273

Liabilities & Shareholders' Equity

Total Current Liabilities411,797
Long-term Liabilities32,335
Total Stockholder Equity1,220,585
Total Current Liabilities
Accounts payable 236,871
Other Current Liabilities 823
Total Current Liabilities  (as reported)411,797
Total Current Liabilities  (calculated)237,693
+/- 174,104
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt3,480
Long-term Liabilities  (as reported)32,335
Long-term Liabilities  (calculated)3,480
+/- 28,856
Total Stockholder Equity
Retained Earnings 392,897
Total Stockholder Equity (as reported)1,220,585
Total Stockholder Equity (calculated)392,897
+/- 827,689
Other
Capital Stock435,162
Common Stock Shares Outstanding 435,162
Net Invested Capital 1,220,585
Net Working Capital 727,175
Property Plant and Equipment Gross 522,825



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
363,372
508,751
552,356
1,016,628
1,234,973
1,304,612
1,360,062
1,495,569
1,664,718
1,664,7181,495,5691,360,0621,304,6121,234,9731,016,628552,356508,751363,372
   > Total Current Assets 
0
0
260,147
677,232
846,277
901,347
894,955
1,009,158
1,138,972
1,138,9721,009,158894,955901,347846,277677,232260,14700
       Cash And Cash Equivalents 
77,559
136,312
89,274
75,370
154,275
159,682
219,520
243,774
519,322
519,322243,774219,520159,682154,27575,37089,274136,31277,559
       Short-term Investments 
0
0
78,500
386,707
0
369,900
356,000
467,775
287,000
287,000467,775356,000369,9000386,70778,50000
       Net Receivables 
13,877
32,750
19,649
150,566
261,381
274,699
228,777
192,310
219,228
219,228192,310228,777274,699261,381150,56619,64932,75013,877
       Inventory 
27,011
35,203
51,519
39,063
9,935
14,044
21,682
22,677
32,541
32,54122,67721,68214,0449,93539,06351,51935,20327,011
   > Long-term Assets 
0
0
292,209
339,397
388,697
403,265
465,107
486,411
525,746
525,746486,411465,107403,265388,697339,397292,20900
       Property Plant Equipment 
158,285
195,062
229,668
222,728
291,301
310,345
314,186
324,143
333,734
333,734324,143314,186310,345291,301222,728229,668195,062158,285
       Goodwill 
215
215
215
215
215
0
0
0
0
0000215215215215215
       Intangible Assets 
6,596
11,237
31,906
42,204
44,158
48,046
65,037
81,547
62,454
62,45481,54765,03748,04644,15842,20431,90611,2376,596
       Long-term Assets Other 
0
0
11,701
56,478
22,887
9,478
8,800
3,850
25,286
25,2863,8508,8009,47822,88756,47811,70100
> Total Liabilities 
77,091
105,824
92,935
158,585
337,334
374,560
376,853
428,305
444,133
444,133428,305376,853374,560337,334158,58592,935105,82477,091
   > Total Current Liabilities 
77,091
105,824
85,432
151,591
332,870
368,406
368,852
419,258
411,797
411,797419,258368,852368,406332,870151,59185,432105,82477,091
       Short-term Debt 
0
0
0
0
26,605
0
0
0
0
000026,6050000
       Short Long Term Debt 
0
0
0
0
26,605
0
0
0
0
000026,6050000
       Accounts payable 
5,132
7,212
1,234
944
11,275
9,696
9,262
244,632
236,871
236,871244,6329,2629,69611,2759441,2347,2125,132
       Other Current Liabilities 
71,958
98,612
71,929
57,829
69,906
74,812
74,488
149,617
823
823149,61774,48874,81269,90657,82971,92998,61271,958
   > Long-term Liabilities 
0
0
7,503
6,994
4,464
6,154
8,001
9,047
32,335
32,3359,0478,0016,1544,4646,9947,50300
       Other Liabilities 
0
0
7,503
6,994
4,464
6,154
8,001
6,699
0
06,6998,0016,1544,4646,9947,50300
       Deferred Long Term Liability 
0
16,328
23,766
36,572
26,608
31,501
52,915
73,355
0
073,35552,91531,50126,60836,57223,76616,3280
> Total Stockholder Equity
286,192
402,904
459,421
858,044
897,639
930,052
983,209
1,067,264
1,220,585
1,220,5851,067,264983,209930,052897,639858,044459,421402,904286,192
   Common Stock
2,100
360,000
360,000
423,000
423,000
423,000
423,000
435,919
0
0435,919423,000423,000423,000423,000360,000360,0002,100
   Retained Earnings 
247,533
21,708
76,624
178,211
217,807
250,220
289,609
346,511
392,897
392,897346,511289,609250,220217,807178,21176,62421,708247,533
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
0
0
0
0
0
0
13,767
19,072
0
019,07213,767000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,392,563
Cost of Revenue-685,040
Gross Profit707,523707,523
 
Operating Income (+$)
Gross Profit707,523
Operating Expense-1,229,767
Operating Income162,796-522,244
 
Operating Expense (+$)
Research Development101,798
Selling General Administrative334,594
Selling And Marketing Expenses-
Operating Expense1,229,767436,392
 
Net Interest Income (+$)
Interest Income2,274
Interest Expense-392
Other Finance Cost-1,898
Net Interest Income3,780
 
Pretax Income (+$)
Operating Income162,796
Net Interest Income3,780
Other Non-Operating Income Expenses-
Income Before Tax (EBT)241,019162,796
EBIT - interestExpense = -392
236,211
236,604
Interest Expense392
Earnings Before Interest and Taxes (EBIT)-241,411
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax241,019
Tax Provision-4,808
Net Income From Continuing Ops236,211236,211
Net Income236,211
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--3,780
 

Technical Analysis of Tibet Weixinkang Medicine Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tibet Weixinkang Medicine Co Ltd. The general trend of Tibet Weixinkang Medicine Co Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tibet Weixinkang Medicine Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tibet Weixinkang Medicine Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 8.69 < 8.69 < 9.07.

The bearish price targets are: 7.24 > 6.3134553802009 > 6.3.

Tweet this
Tibet Weixinkang Medicine Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tibet Weixinkang Medicine Co Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tibet Weixinkang Medicine Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tibet Weixinkang Medicine Co Ltd. The current macd is -0.07849412.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tibet Weixinkang Medicine Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tibet Weixinkang Medicine Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tibet Weixinkang Medicine Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Tibet Weixinkang Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartTibet Weixinkang Medicine Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tibet Weixinkang Medicine Co Ltd. The current adx is 21.80.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tibet Weixinkang Medicine Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Tibet Weixinkang Medicine Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tibet Weixinkang Medicine Co Ltd. The current sar is 7.24.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Tibet Weixinkang Medicine Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tibet Weixinkang Medicine Co Ltd. The current rsi is 54.70. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Tibet Weixinkang Medicine Co Ltd Daily Relative Strength Index (RSI) ChartTibet Weixinkang Medicine Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tibet Weixinkang Medicine Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tibet Weixinkang Medicine Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Tibet Weixinkang Medicine Co Ltd Daily Stochastic Oscillator ChartTibet Weixinkang Medicine Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tibet Weixinkang Medicine Co Ltd. The current cci is 47.58.

Tibet Weixinkang Medicine Co Ltd Daily Commodity Channel Index (CCI) ChartTibet Weixinkang Medicine Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tibet Weixinkang Medicine Co Ltd. The current cmo is 18.06.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Tibet Weixinkang Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) ChartTibet Weixinkang Medicine Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tibet Weixinkang Medicine Co Ltd. The current willr is -14.48275862.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Tibet Weixinkang Medicine Co Ltd Daily Williams %R ChartTibet Weixinkang Medicine Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tibet Weixinkang Medicine Co Ltd.

Tibet Weixinkang Medicine Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tibet Weixinkang Medicine Co Ltd. The current atr is 0.33276619.

Tibet Weixinkang Medicine Co Ltd Daily Average True Range (ATR) ChartTibet Weixinkang Medicine Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tibet Weixinkang Medicine Co Ltd. The current obv is -4,264,862.

Tibet Weixinkang Medicine Co Ltd Daily On-Balance Volume (OBV) ChartTibet Weixinkang Medicine Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tibet Weixinkang Medicine Co Ltd. The current mfi is 49.67.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tibet Weixinkang Medicine Co Ltd Daily Money Flow Index (MFI) ChartTibet Weixinkang Medicine Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tibet Weixinkang Medicine Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-20BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Tibet Weixinkang Medicine Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tibet Weixinkang Medicine Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.696
Ma 20Greater thanMa 508.208
Ma 50Greater thanMa 1008.182
Ma 100Greater thanMa 2009.106
OpenGreater thanClose8.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tibet Weixinkang Medicine Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Tibet Weixinkang Medicine Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tibet Weixinkang Medicine Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tibet Weixinkang Medicine Co Ltd

I send you an email if I find something interesting about Tibet Weixinkang Medicine Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Tibet Weixinkang Medicine Co Ltd.

Receive notifications about Tibet Weixinkang Medicine Co Ltd in your mailbox!